The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Oligonucleotide-Global Market Insights and Sales Trends 2025
Synopsis
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
The global Oligonucleotide market size is expected to reach US$ 2493.1 million by 2029, growing at a CAGR of 10.1% from 2023 to 2029. The market is mainly driven by the significant applications of Oligonucleotide in various end use industries. The expanding demands from the Gene Chip, Electrophoresis and Fluorescence In Situ Hybridization,, are propelling Oligonucleotide market. DNA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RNA segment is estimated at % CAGR for the next seven-year period.
Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.
In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oligonucleotide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oligonucleotide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oligonucleotide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oligonucleotide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oligonucleotide covered in this report include Abbott Molecular, PerkinElmer, SciGene Corporation, Roche NimbleGen and CytoTest, etc.
The global Oligonucleotide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Molecular
PerkinElmer
SciGene Corporation
Roche NimbleGen
CytoTest
Global Oligonucleotide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oligonucleotide market, Segment by Type:
DNA
RNA
Global Oligonucleotide market, by Application
Gene Chip
Electrophoresis
Fluorescence In Situ Hybridization
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oligonucleotide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oligonucleotide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Oligonucleotides are short nucleic acid polymers used in research, genetic testing and forensics.
Oligonucleotides are usually made up of 13 to 25 nucleotides and are designed to hybridize specifically to DNA or RNA sequences. Solid-phase clinical synthesis is used to manufacture these small bits of nucleic acid for use in polymerase chain reaction (PCR), DNA sequencing, library construction and artificial gene synthesis.
The global Oligonucleotide market size is expected to reach US$ 2493.1 million by 2029, growing at a CAGR of 10.1% from 2023 to 2029. The market is mainly driven by the significant applications of Oligonucleotide in various end use industries. The expanding demands from the Gene Chip, Electrophoresis and Fluorescence In Situ Hybridization,, are propelling Oligonucleotide market. DNA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the RNA segment is estimated at % CAGR for the next seven-year period.
Global Oligonucleotides key players include Integrated DNA Technologies, Agilent, Sigma-aldrich, Eurofins Genomics, L.G.C Biosearch Technologies, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 35%, followed by Europe and China, both have a share over 35percent.
In terms of product, DNA Oligos is the largest segment, with a share over 65%. And in terms of application, the largest application is Research, followed by Pharmaceutical.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oligonucleotide, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oligonucleotide market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oligonucleotide market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oligonucleotide sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oligonucleotide covered in this report include Abbott Molecular, PerkinElmer, SciGene Corporation, Roche NimbleGen and CytoTest, etc.
The global Oligonucleotide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Molecular
PerkinElmer
SciGene Corporation
Roche NimbleGen
CytoTest
Global Oligonucleotide market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oligonucleotide market, Segment by Type:
DNA
RNA
Global Oligonucleotide market, by Application
Gene Chip
Electrophoresis
Fluorescence In Situ Hybridization
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oligonucleotide manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oligonucleotide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Oligonucleotide Market Overview
1.1 Oligonucleotide Product Overview
1.2 Oligonucleotide Market Segment by Type
1.2.1 DNA
1.2.2 RNA
1.3 Global Oligonucleotide Market Size by Type
1.3.1 Global Oligonucleotide Market Size Overview by Type (2018-2029)
1.3.2 Global Oligonucleotide Historic Market Size Review by Type (2018-2023)
1.3.3 Global Oligonucleotide Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oligonucleotide Sales Breakdown by Type (2018-2023)
1.4.2 Europe Oligonucleotide Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Oligonucleotide Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Oligonucleotide Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Oligonucleotide Sales Breakdown by Type (2018-2023)
2 Global Oligonucleotide Market Competition by Company
2.1 Global Top Players by Oligonucleotide Sales (2018-2023)
2.2 Global Top Players by Oligonucleotide Revenue (2018-2023)
2.3 Global Top Players by Oligonucleotide Price (2018-2023)
2.4 Global Top Manufacturers Oligonucleotide Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oligonucleotide Market Competitive Situation and Trends
2.5.1 Oligonucleotide Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Oligonucleotide Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oligonucleotide as of 2022)
2.7 Date of Key Manufacturers Enter into Oligonucleotide Market
2.8 Key Manufacturers Oligonucleotide Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oligonucleotide Status and Outlook by Region
3.1 Global Oligonucleotide Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Oligonucleotide Historic Market Size by Region
3.2.1 Global Oligonucleotide Sales in Volume by Region (2018-2023)
3.2.2 Global Oligonucleotide Sales in Value by Region (2018-2023)
3.2.3 Global Oligonucleotide Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Oligonucleotide Forecasted Market Size by Region
3.3.1 Global Oligonucleotide Sales in Volume by Region (2024-2029)
3.3.2 Global Oligonucleotide Sales in Value by Region (2024-2029)
3.3.3 Global Oligonucleotide Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Oligonucleotide by Application
4.1 Oligonucleotide Market Segment by Application
4.1.1 Gene Chip
4.1.2 Electrophoresis
4.1.3 Fluorescence In Situ Hybridization
4.2 Global Oligonucleotide Market Size by Application
4.2.1 Global Oligonucleotide Market Size Overview by Application (2018-2029)
4.2.2 Global Oligonucleotide Historic Market Size Review by Application (2018-2023)
4.2.3 Global Oligonucleotide Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oligonucleotide Sales Breakdown by Application (2018-2023)
4.3.2 Europe Oligonucleotide Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Oligonucleotide Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Oligonucleotide Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Oligonucleotide Sales Breakdown by Application (2018-2023)
5 North America Oligonucleotide by Country
5.1 North America Oligonucleotide Historic Market Size by Country
5.1.1 North America Oligonucleotide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Oligonucleotide Sales in Volume by Country (2018-2023)
5.1.3 North America Oligonucleotide Sales in Value by Country (2018-2023)
5.2 North America Oligonucleotide Forecasted Market Size by Country
5.2.1 North America Oligonucleotide Sales in Volume by Country (2024-2029)
5.2.2 North America Oligonucleotide Sales in Value by Country (2024-2029)
6 Europe Oligonucleotide by Country
6.1 Europe Oligonucleotide Historic Market Size by Country
6.1.1 Europe Oligonucleotide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Oligonucleotide Sales in Volume by Country (2018-2023)
6.1.3 Europe Oligonucleotide Sales in Value by Country (2018-2023)
6.2 Europe Oligonucleotide Forecasted Market Size by Country
6.2.1 Europe Oligonucleotide Sales in Volume by Country (2024-2029)
6.2.2 Europe Oligonucleotide Sales in Value by Country (2024-2029)
7 Asia-Pacific Oligonucleotide by Region
7.1 Asia-Pacific Oligonucleotide Historic Market Size by Region
7.1.1 Asia-Pacific Oligonucleotide Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Oligonucleotide Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Oligonucleotide Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Oligonucleotide Forecasted Market Size by Region
7.2.1 Asia-Pacific Oligonucleotide Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Oligonucleotide Sales in Value by Region (2024-2029)
8 Latin America Oligonucleotide by Country
8.1 Latin America Oligonucleotide Historic Market Size by Country
8.1.1 Latin America Oligonucleotide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Oligonucleotide Sales in Volume by Country (2018-2023)
8.1.3 Latin America Oligonucleotide Sales in Value by Country (2018-2023)
8.2 Latin America Oligonucleotide Forecasted Market Size by Country
8.2.1 Latin America Oligonucleotide Sales in Volume by Country (2024-2029)
8.2.2 Latin America Oligonucleotide Sales in Value by Country (2024-2029)
9 Middle East and Africa Oligonucleotide by Country
9.1 Middle East and Africa Oligonucleotide Historic Market Size by Country
9.1.1 Middle East and Africa Oligonucleotide Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Oligonucleotide Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Oligonucleotide Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Oligonucleotide Forecasted Market Size by Country
9.2.1 Middle East and Africa Oligonucleotide Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Oligonucleotide Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott Molecular
10.1.1 Abbott Molecular Company Information
10.1.2 Abbott Molecular Introduction and Business Overview
10.1.3 Abbott Molecular Oligonucleotide Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Molecular Oligonucleotide Products Offered
10.1.5 Abbott Molecular Recent Development
10.2 PerkinElmer
10.2.1 PerkinElmer Company Information
10.2.2 PerkinElmer Introduction and Business Overview
10.2.3 PerkinElmer Oligonucleotide Sales, Revenue and Gross Margin (2018-2023)
10.2.4 PerkinElmer Oligonucleotide Products Offered
10.2.5 PerkinElmer Recent Development
10.3 SciGene Corporation
10.3.1 SciGene Corporation Company Information
10.3.2 SciGene Corporation Introduction and Business Overview
10.3.3 SciGene Corporation Oligonucleotide Sales, Revenue and Gross Margin (2018-2023)
10.3.4 SciGene Corporation Oligonucleotide Products Offered
10.3.5 SciGene Corporation Recent Development
10.4 Roche NimbleGen
10.4.1 Roche NimbleGen Company Information
10.4.2 Roche NimbleGen Introduction and Business Overview
10.4.3 Roche NimbleGen Oligonucleotide Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Roche NimbleGen Oligonucleotide Products Offered
10.4.5 Roche NimbleGen Recent Development
10.5 CytoTest
10.5.1 CytoTest Company Information
10.5.2 CytoTest Introduction and Business Overview
10.5.3 CytoTest Oligonucleotide Sales, Revenue and Gross Margin (2018-2023)
10.5.4 CytoTest Oligonucleotide Products Offered
10.5.5 CytoTest Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oligonucleotide Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oligonucleotide Industrial Chain Analysis
11.4 Oligonucleotide Market Dynamics
11.4.1 Oligonucleotide Industry Trends
11.4.2 Oligonucleotide Market Drivers
11.4.3 Oligonucleotide Market Challenges
11.4.4 Oligonucleotide Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oligonucleotide Distributors
12.3 Oligonucleotide Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
